← Evidence map

ArticleP & T : a peer-reviewed journal for formulary management2008

Dalbavancin (zeven), a novel glycopeptide for resistant gram-positive organisms.

Jennifer Colabella et al.PubMed ↗Full text ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 19749986